| ²é¿´: 500 | »Ø¸´: 3 | ||
Malyhonгæ (СÓÐÃûÆø)
|
[ÇóÖú]
¼¸¾äÂÛÎÄÇó´óÉñ·Òë³ÉÖÐÎÄ£¬Ð»Ð»
|
|
The above results indicate that the RGD-modified PHBV films prepared by our modification procedure significantly decreased the nonspecific adsorption of fibrinogen from human plasma compared to unmodified or NH3-plasma-treated PHBV films, which might, in turn, decrease the adhesion of platelets and further thrombus formation. Therefore, the above-described surface modification strategy can improve both the blood compatibility and the cellular compatibility of PHBV films. |
» ²ÂÄãϲ»¶
085701Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
321Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
26¿¼Ñе÷¼Á0710 0860
ÒѾÓÐ12È˻ظ´
270»¯¹¤Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸0817»¯Ñ§¹¤³ÌÓë¼¼Êõ£¬Çóµ÷¼Á
ÒѾÓÐ23È˻ظ´
309Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ£¬³õÊԳɼ¨350Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
081700»¯Ñ§¹¤³ÌÓë¼¼Êõ Ò»Ö¾Ô¸Öк£Ñó 323 Çóµ÷¼ÁѧУ
ÒѾÓÐ13È˻ظ´
Çóµ÷¼Á£º085600²ÄÁÏÓ뻯¹¤£¬¿¼²Ä¿Æ»ù£¬×Ü·Ö319
ÒѾÓÐ24È˻ظ´
ÍÁľ304Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
longhua7085
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 1
- Ó¦Öú: 20 (СѧÉú)
- ½ð±Ò: 17804
- ºì»¨: 3
- Ìû×Ó: 2203
- ÔÚÏß: 138.1Сʱ
- ³æºÅ: 724499
- ×¢²á: 2009-03-17
- ÐÔ±ð: GG
- רҵ: ¸ß·Ö×ÓÎïÀíÓë¸ß·Ö×ÓÎïÀí»¯
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
Malyhon: ½ð±Ò+7, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2015-03-05 12:11:48
Malyhon: ½ð±Ò+7, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2015-03-05 12:11:48
| ÉÏÊö½á¹û±íÃ÷£¬Óëδ¸ÄÐÔPHBVĤ»òNH3-Ѫ½¬´¦ÀíµÄPHBVĤÏà±È£¬Í¨¹ýÎÒÃǵĸÄÐÔ·½·¨ÖƱ¸µÄRGD¸ÄÐÔPHBVĤ½µµÍÁËÏËάµ°°×ÔÚÈËÌåѪ½¬ÖеķÇרÐÔÎü¸½£¬´Ó¶ø½µµÍÁËѪС°åµÄÕ³¸½ºÍѪ˨µÄÐγɡ£Òò´Ë£¬ÉÏÊöÌá¼°µÄ±íÃæ¸ÄÐÔ·½·¨¿ÉÒÔÌá¸ßPHBVĤÓëѪҺºÍϸ°ûµÄÏàÈÝÐÔ¡£ |
2Â¥2015-03-03 16:04:08
longhua7085
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 1
- Ó¦Öú: 20 (СѧÉú)
- ½ð±Ò: 17804
- ºì»¨: 3
- Ìû×Ó: 2203
- ÔÚÏß: 138.1Сʱ
- ³æºÅ: 724499
- ×¢²á: 2009-03-17
- ÐÔ±ð: GG
- רҵ: ¸ß·Ö×ÓÎïÀíÓë¸ß·Ö×ÓÎïÀí»¯
3Â¥2015-03-03 16:22:48
SAOpro
½ð³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 1
- Ó¦Öú: 28 (СѧÉú)
- ½ð±Ò: 2612.7
- ºì»¨: 6
- ɳ·¢: 4
- Ìû×Ó: 1278
- ÔÚÏß: 192.6Сʱ
- ³æºÅ: 3360589
- ×¢²á: 2014-08-10
- ÐÔ±ð: GG
- רҵ: Óлú·ÖÎö

4Â¥2015-03-03 21:17:43














»Ø¸´´ËÂ¥